SCHEMBL6318863

SCHEMBL6318863

CCCOP(=O)(NCC)C(CNc1cnc2ccccc2c1)c1ncc(NC)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 10/20 0.38
RAB9A P51151 5/20 0.34
LMNA P02545 3/20 0.34
POLB P06746 2/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HDAC6 Q9UBN7 2/20 0.34
NPC1 O15118 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430774 0.71 RAB9A (0.38) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL6317386 0.68 HDAC6 (0.37) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL6325638 0.66 KDM4E (0.34) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL12895711 0.65 RAB9A (0.59) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL5796726 0.62 RAB9A (0.56) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL6317082 0.62 RAB9A (0.36) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL6397491 0.62 RAB9A (0.39) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL6316811 0.61 LMNA (0.40) RAB9ALMNAPOLBTSHRHSD17B10
SCHEMBL128095 0.60 NPSR1 (0.57) TRPV1RAB9ALMNAPOLBTSHR
SCHEMBL30824513 0.60 NPSR1 (0.57) TRPV1RAB9ALMNAPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US claimed
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL TRPV1 3036/4885RAB9A 2297/4885LMNA 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.